Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity

scientific article published on 19 March 2002

Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/339617
P698PubMed publication ID11920319
P5875ResearchGate publication ID11445062

P50authorHerbert L. DuPontQ29563314
P2093author name stringRobert Steffen
David E Greenberg
Zhi-Dong Jiang
Mangala P Verenker
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
inflammationQ101991
diarrheaQ40878
Enteroaggregative Escherichia coliQ1344595
P304page(s)944-949
P577publication date2002-03-19
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleMarkers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity
P478volume185

Reverse relations

cites work (P2860)
Q36394728A new understanding of enteroaggregative Escherichia coli as an inflammatory pathogen
Q39046503A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital
Q37651476Adhesion of Diarrheagenic Escherichia coli and Inhibition by Glycocompounds Engaged in the Mucosal Innate Immunity
Q37097646Animal models of enteroaggregative Escherichia coli infection
Q30432798Association between TNF-alpha and Entamoeba histolytica diarrhea
Q35690358Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries
Q33675794Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections
Q37191241Characterization and studies of the cellular interaction of native colonization factor CS6 purified from a clinical isolate of enterotoxigenic Escherichia coli
Q36505498Current and future developments in travelers' diarrhea therapy
Q30443288Enteric infections, diarrhea, and their impact on function and development
Q40532416Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation
Q38024836Enteroaggregative Escherichia coli pathotype: a genetically heterogeneous emerging foodborne enteropathogen
Q21328680Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen
Q54509537Enteroaggregative Escherichia coli: An Emerging Pathogen.
Q35716649Enteroaggregative Escherichia coli: an emerging enteric pathogen
Q33689258Enteroaggregative coli: A Pathogen Bridging the North and South
Q45071462Enterotoxigenic Escherichia coli is phagocytosed by macrophages underlying villus-like intestinal epithelial cells: modeling ex vivo innate immune defenses of the human gut.
Q36396783Enterotoxigenic Escherichia coli prevents host NF-κB activation by targeting IκBα polyubiquitination
Q34057621Epidemiology and clinical manifestations of enteroaggregative Escherichia coli
Q40109314Epidemiology of enteroaggregative Escherichia coli infections and associated outcomes in the MAL-ED birth cohort
Q40302349Epithelial cells secrete interleukin-8 in response to adhesion and invasion of diffusely adhering Escherichia coli lacking Afa/Dr genes
Q34294931Escherichia coli expressing EAST1 toxin did not cause an increase of cAMP or cGMP levels in cells, and no diarrhea in 5-day old gnotobiotic pigs
Q35067103Fecal leukocytes in children infected with diarrheagenic Escherichia coli
Q41106623Human norovirus infection and the acute serum cytokine response.
Q94521258Identification and characterisation of enteroaggregative Escherichia coli subtypes associated with human disease
Q36575325Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli.
Q39537395In Silico and In Vitro Studies of Truncated Forms of Flagellin (FliC) of Enteroaggregative Escherichia coli (EAEC).
Q34251481Inflammatory diarrhea due to enteroaggregative Escherichia coli: evidence from clinical and mice model studies
Q33712186Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli
Q39255777Is the interleukin 8 promoter polymorphism rs4073/-251T >A associated with Clostridium difficile infection?
Q37964040Lactoferrin, a key molecule in immune and inflammatory processes
Q96816103Mucus layer modeling of human colonoids during infection with enteroaggragative E. coli
Q30430377Pediatric diarrhea in Southern Ghana: Etiology and association with intestinal inflammation and malnutrition
Q53285940Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.
Q47122481Prediction model and treatment of high-output ileostomy in colorectal cancer surgery
Q34974972Prevention and self-treatment of traveler's diarrhea
Q41837851Proinflammatory fecal mRNA and childhood bacterial enteric infections
Q39695148Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers
Q34595945Simultaneous exposure to Escherichia coli heat-labile and heat-stable enterotoxins increases fluid secretion and alters cyclic nucleotide and cytokine production by intestinal epithelial cells
Q64067847TLR4 Participates in the Inflammatory Response Induced by the AAF/II Fimbriae From Enteroaggregative Escherichia coli on Intestinal Epithelial Cells
Q40046016Travelers' diarrhea: an update on susceptibility, prevention, and treatment
Q46901378Travelers' diarrhea: modern concepts and new developments
Q33235907Travellers' diarrhoea: contemporary approaches to therapy and prevention
Q34585296Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections

Search more.